Skye Bioscience, Common Stock Technical Analysis
| SKYE Stock | USD 2.70 0.16 5.59% |
As of the 24th of December, Skye Bioscience, has the Coefficient Of Variation of (1,025), risk adjusted performance of (0.07), and Variance of 56.75. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Skye Bioscience, Common, as well as the relationship between them. Please validate Skye Bioscience, Common market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Skye Bioscience, is priced more or less accurately, providing market reflects its prevalent price of 2.7 per share. Please also confirm Skye Bioscience, Common jensen alpha, which is currently at (0.74) to double-check the company can sustain itself at a future point.
Skye Bioscience, Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Skye, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SkyeSkye |
Skye Bioscience, Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 18.25 | Strong Buy | 6 | Odds |
Most Skye analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Skye stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Skye Bioscience, Common, talking to its executives and customers, or listening to Skye conference calls.
Skye Bioscience, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Skye Bioscience, Common Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Skye Bioscience, Common volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Skye Bioscience, Common Trend Analysis
Use this graph to draw trend lines for Skye Bioscience, Common. You can use it to identify possible trend reversals for Skye Bioscience, as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Skye Bioscience, price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Skye Bioscience, Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Skye Bioscience, Common applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Skye Bioscience, Common market price will keep on failing further. It has 122 observation points and a regression sum of squares at 6.72, which is the sum of squared deviations for the predicted Skye Bioscience, price change compared to its average price change.About Skye Bioscience, Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Skye Bioscience, Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Skye Bioscience, Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Skye Bioscience, Common price pattern first instead of the macroeconomic environment surrounding Skye Bioscience, Common. By analyzing Skye Bioscience,'s financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Skye Bioscience,'s intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Skye Bioscience, specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Graham Number | 6.07 | 5.76 | Receivables Turnover | 12.07 | 12.68 |
Skye Bioscience, December 24, 2024 Technical Indicators
Most technical analysis of Skye help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Skye from various momentum indicators to cycle indicators. When you analyze Skye charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 4.06 | |||
| Mean Deviation | 4.74 | |||
| Coefficient Of Variation | (1,025) | |||
| Standard Deviation | 7.53 | |||
| Variance | 56.75 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.74) | |||
| Total Risk Alpha | (0.97) | |||
| Treynor Ratio | 4.05 | |||
| Maximum Drawdown | 42.81 | |||
| Value At Risk | (7.88) | |||
| Potential Upside | 9.46 | |||
| Skewness | (2.46) | |||
| Kurtosis | 14.37 |
Complementary Tools for Skye Stock analysis
When running Skye Bioscience,'s price analysis, check to measure Skye Bioscience,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skye Bioscience, is operating at the current time. Most of Skye Bioscience,'s value examination focuses on studying past and present price action to predict the probability of Skye Bioscience,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skye Bioscience,'s price. Additionally, you may evaluate how the addition of Skye Bioscience, to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |